Partnerships for Research in Implementation Science for Equity in Heart and Lung diseases training program (PRISE-HL T32)
Partnerships for Research in Implementation Science for Equity in Heart and Lung diseases training program (PRISE-HL T32)
批准号:
10553831
负责人:
Adithya Cattamanchi
金额:
$46.86万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-07-01 至 2028-06-30
中文摘要
摘要
实施科学(IMS)是一个研究分支,专注于改善对证据的吸收-
将卫生干预措施纳入现实世界环境。IMS有望产生新的知识来结束
我们所知道的可以优化健康和医疗保健的东西与日常实践中发生的事情之间的差距,
这可能对解决由于未能
向所有人群提供循证实践。实施中研究伙伴关系的目标
心肺疾病公平科学(Enterprise-HL)T32计划是为杰出的
科学家有能力通过实施科学和技术领域的跨学科培训来扩大他们的学术基础
有助于转变对心脏的循证干预措施的吸收和交付的健康公平方法
以及真实世界环境中的肺部疾病。加州大学旧金山分校是世界领先的健康科学校园之一,这
该计划将建立在心肺疾病研究的现有优势以及建立的基础设施上
通过最近成立的加州大学旧金山分校企业中心,一个将IMS聚集在一起的创新研究中心
在当地卫生系统和公共卫生部门拥有一线实施者的研究人员。一名医生-
科学家和公共卫生培训的流行病学家,在应用实施方面都有丰富的经验
从科学到健康公平,以及IMS培训的领导者,将指导该计划。一次异常的
具有良好跨学科协作记录的优秀教员团队将带来互补
在与心肺疾病相关的临床和转化性研究以及关键的健康公平和/或
实施科学相关学科,包括行为改变、社区参与、健康
经济学、卫生政策、大数据和社会学。此外,该计划还包括与
服务于旧金山湾区不同社区的社区和三级医疗诊所网站
与当地(旧金山)和地区(加州)公共卫生部门合作。一个咨询委员会将
与项目负责人合作,挑选T32学员,监督学员的进度,并寻找机会
完善该计划。受训人员招聘过程将受益于获得大量和多样化的
来自加州大学旧金山分校完善的培训计划的内部候选人,并为我们提供更多机会
继续招募最有前途的外部实习生。每个实习生都将在职业生涯中与导师一起工作
发展委员会确立目标,量身定做教学和实践培训经验,以发展
在实施科学和卫生公平研究的核心领域的能力。学员还将受益于
嵌入式医疗保健提供系统或公共卫生计划轮换,以发展与现实世界的体验
实践变革和新的企业-HL T32计划研讨会,将整合实施科学培训
和健康公平研究。
英文摘要
Summary
Implementation science (ImS) is a branch of research that focuses on the improving the uptake of evidence-
based health interventions into real world settings. ImS holds promise for generating new knowledge to close
the gap between what we know can optimize health and healthcare and what happens in everyday practice,
which may be of particular importance for addressing health inequities that often result because of failure to
deliver evidence-based practice to all populations. The goal of the Partnerships for Research in Implementation
Science for Equity in Heart and Lung (PRISE-HL) diseases T32 program is to provide support to outstanding
scientists equipped to build on their scholarship with interdisciplinary training in implementation science and
health equity approaches to help transform the uptake and delivery of evidence-based interventions for heart
and lung diseases in real-world settings. UCSF is one of the world’s leading health sciences campuses and this
program will build on existing strengths in heart and lung diseases research as well as infrastructure established
through the recently launched UCSF PRISE Center, an innovative research center bringing together ImS
researchers with front-line implementers in local health systems and public health departments. A physician-
scientist and public health trained epidemiologist, both with extensive experience in applying implementation
science to health equity and who are leaders in ImS training, will direct the program. An exceptionally
accomplished group of faculty with strong records of interdisciplinary collaboration will bring complementary
expertise in clinical and translational research related to heart and lung diseases and key health equity and/or
implementation science-relevant disciplines, including behavior change, community engagement, health
economics, health policy, big data, and sociology. In addition, the program includes strong partnerships with
community and tertiary care clinical sites that serve the diverse communities of the San Francisco Bay Area and
with local (San Francisco) and regional (California) Departments of Public Health. An Advisory Committee will
work with the program directors to select T32 trainees, monitor trainees’ progress, and identify opportunities for
improving the program. The trainee recruitment process will benefit from access to a large and diverse pool of
internal candidates from UCSF’s well-established training programs and provide additional opportunities for us
to continue to recruit the most promising external trainees. Each trainee will work with mentors on their career
development committee to establish goals and tailor didactic and hands-on training experiences to develop
competencies in core areas of implementation science and health equity research. Trainees will also benefit from
embedded healthcare delivery system or public health program rotations to develop experience with real-world
practice change and a new PRISE-HL T32 Program Seminar that will integrate training in implementation science
and health equity research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PROgression of Tuberculosis infECTion in young children living with and without HIV: the PROTECT study
-
批准号:10641389
-
项目类别:
-
资助金额:$110.55万
-
财政年份:2023
-
负责人:Adithya Cattamanchi
-
依托单位:
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)
-
批准号:10416088
-
项目类别:
-
资助金额:$397.74万
-
财政年份:2020
-
负责人:Adithya Cattamanchi
-
依托单位:
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)
-
批准号:9981550
-
项目类别:
-
资助金额:$377.43万
-
财政年份:2020
-
负责人:Adithya Cattamanchi
-
依托单位:
Childhood ‘Omics’ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings
-
批准号:10375468
-
项目类别:
-
资助金额:$51.83万
-
财政年份:2020
-
负责人:Adithya Cattamanchi
-
依托单位:
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)
-
批准号:10631188
-
项目类别:
-
资助金额:$101.65万
-
财政年份:2020
-
负责人:Adithya Cattamanchi
-
依托单位:
Rapid Research for Diagnostics Development in TB Network (R2D2 TB Network)
-
批准号:10244868
-
项目类别:
-
资助金额:$399.64万
-
财政年份:2020
-
负责人:Adithya Cattamanchi
-
依托单位:
Childhood ‘Omics’ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings
-
批准号:10677740
-
项目类别:
-
资助金额:$141.08万
-
财政年份:2020
-
负责人:Adithya Cattamanchi
-
依托单位:
Childhood ‘Omics’ and Mycobacterium tuberculosis-derived BiOsignatures (COMBO) for TB diagnosis in high HIV prevalence settings
-
批准号:10811547
-
项目类别:
-
资助金额:$104.0万
-
财政年份:2020
-
负责人:Adithya Cattamanchi
-
依托单位:
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial
-
批准号:10212447
-
项目类别:
-
资助金额:$59.74万
-
财政年份:2018
-
负责人:Adithya Cattamanchi
-
依托单位:
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial
-
批准号:9753350
-
项目类别:
-
资助金额:$61.41万
-
财政年份:2018
-
负责人:Adithya Cattamanchi
-
依托单位:
Options for Delivery of Short-Course Tuberculosis Preventive Therapy: The 3HP Options Trial
-
批准号:10784443
-
项目类别:
-
资助金额:$59.42万
-
财政年份:2018
-
负责人:Adithya Cattamanchi
-
依托单位:
Evaluation of a novel breath sensor for rapid, low-cost diagnosis of tuberculosis in children
-
批准号:9901601
-
项目类别:
-
资助金额:$65.54万
-
财政年份:2018
-
负责人:Adithya Cattamanchi
-
依托单位:
Improving the molecular diagnosis of drug resistant tuberculosis
-
批准号:9007592
-
项目类别:
-
资助金额:$73.1万
-
财政年份:2016
-
负责人:Adithya Cattamanchi
-
依托单位:
SIngle-saMPLE tuberculosis evaluation to facilitate linkage to care: The SIMPLE TB trial
-
批准号:9205264
-
项目类别:
-
资助金额:$64.15万
-
财政年份:2016
-
负责人:Adithya Cattamanchi
-
依托单位:
TB Guidline Observation and Adherence in Low Income Countries (TB GOAL)
-
批准号:8176751
-
项目类别:
-
资助金额:$17.62万
-
财政年份:2011
-
负责人:Adithya Cattamanchi
-
依托单位:
TB Guidline Observation and Adherence in Low Income Countries (TB GOAL)
-
批准号:8286148
-
项目类别:
-
资助金额:$20.14万
-
财政年份:2011
-
负责人:Adithya Cattamanchi
-
依托单位:
Immunodiagnosis of Active Tuberculosis in HIV-infected Patients
-
批准号:8044756
-
项目类别:
-
资助金额:$15.24万
-
财政年份:2009
-
负责人:Adithya Cattamanchi
-
依托单位:
Immunodiagnosis of Active Tuberculosis in HIV-infected Patients
-
批准号:7686415
-
项目类别:
-
资助金额:$15.14万
-
财政年份:2009
-
负责人:Adithya Cattamanchi
-
依托单位:
Immunodiagnosis of Active Tuberculosis in HIV-infected Patients
-
批准号:8451422
-
项目类别:
-
资助金额:$15.24万
-
财政年份:2009
-
负责人:Adithya Cattamanchi
-
依托单位:
Immunodiagnosis of Active Tuberculosis in HIV-infected Patients
-
批准号:8242741
-
项目类别:
-
资助金额:$15.24万
-
财政年份:2009
-
负责人:Adithya Cattamanchi
-
依托单位:
海外基金